Hypoglycemia Associated With Drug–Drug Interactions in Patients With Type 2 Diabetes Mellitus Using Dipeptidylpeptidase-4 Inhibitors

Background: Dipeptidylpeptidase-4 inhibitors (DPP-4i′s) are considered to be safe for patients with type 2 diabetes mellitus (T2DM). However, little is known about drug–drug interactions between DPP-4i′s and concurrent medications. Methods: Data on patients using DPP-4i′s for T2DM during 2011–2017 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray, Chin-Ying, Wu, Victor Chien-Chia, Wang, Chun-Li, Tu, Hui-Tzu, Huang, Yu-Tung, Kuo, Chang-Fu, Chang, Shang-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142266/
https://www.ncbi.nlm.nih.gov/pubmed/34040513
http://dx.doi.org/10.3389/fphar.2021.570835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142266/
https://www.ncbi.nlm.nih.gov/pubmed/34040513
http://dx.doi.org/10.3389/fphar.2021.570835

Ejemplares similares